GLIS3 and type 2 diabetes mellitus: We found that the expected effect (β = 0.15), estimated by multiplying the magnitude of the association between GLIS3-rs7034200 and HOMA-B and of the association between HOMA-B and type 2 diabetes risk, was comparable to the observed effect (β = 0.24, P(exp/obs) = 0.53).